We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

A liver, filled with connected data points.

Fatty Liver, But Not Liver Damage, Common in Type 2 Diabetes

A kaleidoscope-like image of the interior of a crystal.

Giant Stretch in Quantum Materials Confirms 100-Year-Old Prediction

The spire of Glasgow University protruding through the autumnal treeline. River visible. Overcast day.

PFAS Hotspot Found in Glasgow River

Mushrooms Reveal Secret To Building More Stress-Resistant Materials

Banking Data Reveals Early Warning Signs of Cognitive Decline

Earwax Biomarkers for Early Parkinson's Disease Detection

News

Myriad Genetics Acquires Exclusive Rights to RAD51C Cancer Gene

Mutations in the RAD51C gene have been linked to an increased risk for developing hereditary breast and ovarian cancers.

UT Southwestern Research Suggests New Way to Ensure Effectiveness of TB Treatment

By using a “glass mouse” research model study founds that multidrug-resistant TB is caused in patients by speedy drug metabolism.

Important Gene-Regulation Proteins Pinpointed by New Method

A novel technique has been developed and demonstrated at Penn State to map the proteins that read and regulate chromosomes.

Welsh Government Teams up With Oxford Innovation

High Potential Starts programme will support start-up and early stage life science companies in Wales.

American CryoStem Launches New Consumer Website Design

The new website is a sophisticated online destination showcasing the Company's branding and marketing of its core "Collect Process and Store" consumer stem cell service.

UW-Madison Engineer Receives Diagnostics Grant

$2.5 million point-of-care diagnostics grant through grand challenges in global health.

BCCA Joins the Illumina Genome Network

Network expansion making affordable, high quality whole human genome sequencing services accessible world-wide.

Ferrer Initiates Phase III Clinical Studies for Ozenoxacin

Ozenoxacin is available for licensing and commercialization from Ferrer.

Genetic Abnormality Predicts Benefit from Treatment for a Rare Brain Tumor

NIH-funded study shows doubling in survival time for patients with two different chromosomal deletions.

CRB Signs Agreement with Life Technologies

Cambridge Research Biochemicals sign an extension to its Supply & Licence Agreement with Life Technologies - Molecular Probes, significantly expanding its dye labelling offering.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter